Orrick Advises capAI on AI Alliance with R42 Group
2 minute read | May.27.2025
Orrick advised capAI plc (LSE: CPAI), a London Stock Exchange Main Market listed AI innovation business, on its Alliance with R42 Group, LLC, a venture capital firm based in Palo Alto, California.
THE IMPACT
The Alliance with R42, which shall come into effect on 1 June 2025, enhances capAI's operating model (Identify; Incubate; and Invent) by creating a transatlantic platform for sourcing, developing, and commercialising early-stage AI opportunities in media and medicine, with strategic flexibility to pursue exceptional, high-growth opportunities across the broader AI landscape.
The Alliance enables capAI to access high-quality innovation with capital efficiency by leveraging R42's existing network and infrastructure, positioning capAI to pursue AI breakthrough opportunities.
Richard Edwards, Executive Chairman of capAI, shared:
"This Alliance with R42 marks a major step forward in executing our refined operating strategy. Together, we are establishing a powerful, transatlantic innovation platform that brings together world-class AI expertise, capital efficiency, and public market access. The projects under review exemplify our commitment to transformative AI solutions in media and medicine; sectors we believe offer exceptional long-term growth potential and strong alignment with our vision of AI-empowered value creation."
Professor Ronjon Nag, Founder of R42, added:
"The formalisation of this Alliance establishes a unique innovation pipeline, linking entrepreneurial AI ventures with the resources and execution capabilities needed to scale. By combining R42's venture-building expertise with capAI's public market access, we can accelerate the commercialisation of breakthrough technologies. This collaboration reflects our shared commitment to capital-efficient innovation and the pursuit of high-impact AI opportunities in media and medicine."
THE TEAM
The Orrick team was led by Ed Dyson and included Faraaz Samadi, Rebecca Servian, Michael Wiesner, Shannon Yavorsky, Abigail Parkin, Charles Sheldon, and James Labovitch.